Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study

Hydroxychloroquine has been touted as a potential COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has also been proposed as a treatment of critically ill patients. In this retrospective observational cohort study drawn from electronic health records we sought to describe the association betwe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS One
Hauptverfasser: Ip, Andrew, Berry, Donald A., Hansen, Eric, Goy, Andre H., Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Berry, Scott M., Berry, Nicholas S., Mathura, Shivam, Sawczuk, Ihor S., Biran, Noa, Go, Ronaldo C., Sperber, Steven, Piwoz, Julia A., Balani, Bindu, Cicogna, Cristina, Sebti, Rani, Zuckerman, Jerry, Rose, Keith M., Tank, Lisa, Jacobs, Laurie G., Korcak, Jason, Timmapuri, Sarah L., Underwood, Joseph P., Sugalski, Gregory, Barsky, Carol, Varga, Daniel W., Asif, Arif, Landolfi, Joseph C., Goldberg, Stuart L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2020
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425928/
https://ncbi.nlm.nih.gov/pubmed/32790733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0237693
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge